Profiel
Mr. Roy M.
Gonzales was previously employed as a Chief Financial & Accounting Officer by Ventyx Biosciences, Inc., a Vice President-Finance by Landos Biopharma, Inc., and a Vice President-Finance & SEC Reporting by Histogen, Inc. He received his undergraduate degree from Old Dominion University, an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from the University of California, Los Angeles.
Eerdere bekende functies van Roy Gonzales
| Bedrijven | Functie | Einde |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Financieel Directeur/CFO | 04-03-2026 |
| LANDOS BIOPHARMA, INC. | Corporate Officer/Principal | 01-06-2022 |
| HISTOGEN INC. | Corporate Officer/Principal | 01-09-2021 |
Opleiding van Roy Gonzales
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
















